Pharmaceuticals

Piramal Healthcare to shut down UK unit

02 Apr 2009

Glenmark to withdraw painkiller from US market

02 Apr 2009

Aurobindo's HIV drug, Ranbaxy's epillepsy drug get USFDA nod

01 Apr 2009

Ranbaxy to launch Daiichi's hypertension drug in India

31 Mar 2009

Novartis's open offer for Indian arm to begin on 14 May

27 Mar 2009

Strides Arcolab gets USFDA approval for its Bangalore facility

27 Mar 2009

US pharmaceutical company Hospira to cut 10 per cent of workforce

25 Mar 2009

Novartis makes open offer for 39 per cent in Indian arm

25 Mar 2009

Swiss drug maker Novartis AG will acquire an additional 39 per cent in its Indian subsidiary Novartis India Ltd from the public for about Rs440 crore to raise its stake to 90 per cent.

Bristol-Myers, Syngene open new R&D facility

24 Mar 2009

UK, Australia okay drugs from Ranbaxy plant

24 Mar 2009

Hikal plans to take over its own pharma co

23 Mar 2009

Dr Reddy’s pulling out of small global markets

21 Mar 2009

Dr Reddy’s sales in Russia and CIS top $150 million

19 Mar 2009

Matrix gets tentative US FDA nod for HIV inhibitor drug

13 Mar 2009

US court clears Dr Reddy’s in Omeprazole Mg OTC litigation

13 Mar 2009

Pharma majors under merger pressure after Merck-Schering deal

12 Mar 2009

Biocon arm Syngene in R&D pact with DuPont Crop Protection

09 Mar 2009

Pfizer sells insulin assets to Anti-diabetes drugmaker MannKind for $33 million

09 Mar 2009

Takeda shares plummet as FDA delays new drug

09 Mar 2009

Ranbaxy's cardio drug `Ramipril' gets US FDA approval

09 Mar 2009

New bill seeks to bring plants exporting drugs to US under FDA inspection

05 Mar 2009

UK watchdog cautions parents giving cold and cough medicines to children

02 Mar 2009

US drug firm Cephalon makes $329 million offer for Australia's Arana

27 Feb 2009

Ranbaxy plant in India falsified data: US FDA

25 Feb 2009

US, China in race for top slot in global wind industry

17 Feb 2009

US and China are leading the race on adding new installed wind power capacity, while in Europe it has emerged the top source for new power generation capacity addition